Regulatory RNA of SYNGAP1 gene (None established; if specific regulatory RNAs are identified, names such as SYNGAP1-AS1 (for antisense RNA) are sometimes used[6].)

Regulatory RNAs of the SYNGAP1 gene encompass a variety of non-coding RNA molecules, including long non-coding RNAs, antisense RNAs, enhancer RNAs, and promoter-associated RNAs, which modulate the levels and activity of SYNGAP1 mRNA and protein in neurons[3][6]. These RNAs act by influencing transcription, alternative splicing, mRNA stability, and decay, shaping the amount of SYNGAP1 protein available, thereby impacting synaptic development, plasticity, and cognitive function[5][6][7]. Alterations, mutations, or aberrant regulation of these RNAs contribute to neurodevelopmental diseases, and RNA-based therapies (such as antisense oligonucleotides) targeting these regulatory elements are being developed to restore normal SYNGAP1 function and treat associated disorders[3][5][7]. Because this entry refers collectively to several regulatory RNA types rather than one molecule, it is not an ideal structured target designation, and the specific RNA (e.g., SYNGAP1-AS1) should be named where possible for clarity[6].

Other names

SYNGAP1 regulatory RNASYNGAP1-AS1 (for the antisense RNA)[6]SYNGAP1 non-coding RNA

Upregulation of SYNGAP1 expression by blocking unproductive splicing or nonsense-mediated decay of SYNGAP1 mRNA[5][7] Modulation of regulatory RNA stability or expression to alter SYNGAP1 gene output[3][5][7]